7251 - 7300 of 9038 Results
Title
Year
- Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”2021RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
- MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression2021RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
- Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease2021RESTRICTEDTitle: Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2419End Page: 2425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28712Citation Count: 24
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://pub.dzne.de/record/163488Citation Count: 29
- A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 Patients2021RESTRICTEDTitle: A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 PatientsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2446End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28718Citation Count: 8
- Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs2021RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 80
- Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”2021RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 116
-
OPENTitle: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 7End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdfCitation Count: 6
-
OPENTitle: Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 16End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.010Best OA location URL: http://www.prd-journal.com/article/S1353802020308609/pdfCitation Count: 61
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 7
- Essential tremor and cognitive decline2021RESTRICTEDTitle: Essential tremor and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 125End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012Citation Count: 3
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 84
-
OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 21
- White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia2021OPENTitle: White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 111Issue #:Start Page: 54End Page: 63Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.11.007Citation Count: 74
- Genetic variants in progranulin upstream open reading frames increase downstream protein expression2021OPENTitle: Genetic variants in progranulin upstream open reading frames increase downstream protein expressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 110Issue #:Start Page: 113End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.09.007Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.09.007Citation Count: 2
- Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data2022RESTRICTEDTitle: Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary dataJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 117Issue #:Start Page: 212End Page: 221Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2022.03.019Citation Count: 10
-
OPENTitle: Protein interaction network analysis reveals genetic enrichment of immune system genes in frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 116Issue #:Start Page: 67End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2022.03.018Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2022.03.018Citation Count: 3
-
OPENTitle: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 templateJournal Name: NeuroImagePublisher: Elsevier BVVol: 257Issue #:Start Page: 119266End Page: 119266Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266Best OA location URL: https://doi.org/10.1016/j.neuroimage.2022.119266Citation Count: 17
- Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation2022OPENTitle: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 364End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015Citation Count: 5
- Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum2022RESTRICTEDTitle: Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellumJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #: 9Start Page: 924End Page: 931Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.05.002Citation Count: 6
- La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles2022RESTRICTEDTitle: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnellesJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152Citation Count: 0
- Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagisme2022RESTRICTEDTitle: Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagismeJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.151Citation Count: 0
- ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time2022RESTRICTEDTitle: ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming TimeJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 5Start Page: S6End Page: S7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.012Citation Count: 0
- ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient2022RESTRICTEDTitle: ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury PatientJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 5Start Page: S6End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.011Citation Count: 0
- Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease2021RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 19
-
OPENTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 26
-
OPENTitle: GDNF signaling in subjects with minimal motor deficits and Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105298End Page: 105298Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105298Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105298Citation Count: 30
-
OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 17
-
OPENTitle: A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105612End Page: 105612Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105612Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105612Citation Count: 9
-
OPENTitle: Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 167Issue #:Start Page: 105668End Page: 105668Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105668Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105668Citation Count: 31
-
OPENTitle: Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 174Issue #:Start Page: 105858End Page: 105858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105858Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105858Citation Count: 5
-
OPENTitle: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 174Issue #:Start Page: 105885End Page: 105885Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105885Citation Count: 19
-
OPENTitle: The potential of biomaterials for central nervous system cellular repairJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 144Issue #:Start Page: 104971End Page: 104971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuint.2021.104971Best OA location URL: https://doi.org/10.1016/j.neuint.2021.104971Citation Count: 37
-
OPENTitle: Anxiety in Parkinson's disease: A resting-state high density EEG studyJournal Name: Neurophysiologie CliniquePublisher: Elsevier BVVol: 52Issue #: 3Start Page: 202End Page: 211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neucli.2022.01.001Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0987705322000016?via%3DihubCitation Count: 20
- The association between multiple risk factors, clinical correlations and molecular insights in Parkinson’s disease patients from Tamil Nadu population, India2021RESTRICTEDTitle: The association between multiple risk factors, clinical correlations and molecular insights in Parkinson’s disease patients from Tamil Nadu population, IndiaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 755Issue #:Start Page: 135903End Page: 135903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135903Citation Count: 26
- Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brain2021RESTRICTEDTitle: Autoradiographic labelling of 5-HT3 receptors in the hemi-parkinsonian rat brainJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 177Issue #:Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2021.12.004Citation Count: 3
- Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum2020RESTRICTEDTitle: Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.007Citation Count: 66
- Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease2020RESTRICTEDTitle: Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 120End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.016Citation Count: 14
- Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers2020RESTRICTEDTitle: Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockersJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 100Issue #:Start Page: 22End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.12.011Citation Count: 33
-
OPENTitle: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approachJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 102Issue #:Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.02.001Citation Count: 20
- Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses2021RESTRICTEDTitle: Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 105Issue #:Start Page: 378.e1End Page: 378.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.04.011Citation Count: 16
-
OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 7
- Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections2021RESTRICTEDTitle: Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and ProjectionsJournal Name: Value in HealthPublisher: Elsevier BVVol: 24Issue #: 7Start Page: 1024End Page: 1029Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jval.2021.01.009Citation Count: 4
- Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separation2020RESTRICTEDTitle: Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separationJournal Name: Matrix BiologyPublisher: Elsevier BVVol: 100-101Issue #:Start Page: 9End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.matbio.2020.11.003Citation Count: 34
-
OPENTitle: Detect and correct bias in multi-site neuroimaging datasetsJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 67Issue #:Start Page: 101879End Page: 101879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.media.2020.101879Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1361841520302437?via%3DihubCitation Count: 120
- Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseases2022RESTRICTEDTitle: Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseasesJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 78Issue #:Start Page: 102419End Page: 102419Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.media.2022.102419Citation Count: 20
- Physical inactivity is associated with Parkinson's disease mild cognitive impairment and dementia2022OPENTitle: Physical inactivity is associated with Parkinson's disease mild cognitive impairment and dementiaJournal Name: Mental Health and Physical ActivityPublisher: Elsevier BVVol: 23Issue #:Start Page: 100461End Page: 100461Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mhpa.2022.100461Best OA location URL: https://doi.org/10.1016/j.mhpa.2022.100461Citation Count: 16
-
OPENTitle: Physical activity as a mediator of anxiety and cognitive functioning in Parkinson's diseaseJournal Name: Mental Health and Physical ActivityPublisher: Elsevier BVVol: 20Issue #:Start Page: 100382End Page: 100382Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.mhpa.2021.100382Best OA location URL: https://doi.org/10.1016/j.mhpa.2021.100382Citation Count: 9
- ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system2021OPENTitle: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation systemJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 9Start Page: 2013End Page: 2030.e9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001Best OA location URL: http://www.cell.com/article/S1097276521001696/pdfCitation Count: 103